VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

NWAM LLC's Holding History (CIK: 0001655006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 5,038 Value ($000) $2,395 Avg Close $431.03 Range $392.50 - $464.44

Q3 2025

Shares 5,077 Value ($000) $2,119 Avg Close $417.92 Range $362.50 - $484.56

Q2 2025

Shares 5,087 Value ($000) $2,320 Avg Close $460.83 Range $416.60 - $510.77

Q1 2025

Shares 4,742 Value ($000) $2,299 Avg Close $466.00 Range $397.25 - $519.68

Q4 2024

Shares 6,178 Value ($000) $2,488 Avg Close $463.53 Range $377.85 - $519.88

Q3 2024

Shares 5,000 Value ($000) $2,325 Avg Close $480.37 Range $456.07 - $510.64

Q2 2024

Shares 4,992 Value ($000) $2,340 Avg Close $434.05 Range $391.01 - $486.43

Q1 2024

Shares 4,860 Value ($000) $1,994 Avg Close $422.74 Range $403.43 - $448.40

Q4 2023

Shares 4,862 Value ($000) $1,978 Avg Close $369.42 Range $341.85 - $413.00

Q3 2023

Shares 4,851 Value ($000) $1,687 Avg Close $349.73 Range $335.82 - $367.00

Q2 2023

Shares 4,861 Value ($000) $1,711 Avg Close $336.94 Range $313.47 - $354.94

Q1 2023

Shares 4,873 Value ($000) $1,535 Avg Close $299.93 Range $282.21 - $325.19

Q4 2022

Shares 4,948 Value ($000) $1,429 Avg Close $304.77 Range $283.58 - $324.75

Q3 2022

Shares 4,918 Value ($000) $1,424 Avg Close $287.72 Range $271.61 - $305.95

Q2 2022

Shares 4,812 Value ($000) $1,389 Avg Close $267.66 Range $233.01 - $293.17

Q1 2022

Shares 5,773 Value ($000) $1,507 Avg Close $237.33 Range $214.66 - $263.58

Q4 2021

Shares 5,774 Value ($000) $1,268 Avg Close $194.45 Range $176.36 - $224.49

Q3 2021

Shares 2,435 Value ($000) $442 Avg Close $195.24 Range $180.02 - $204.88

Q2 2020

Shares 1,169 Value ($000) $339 Avg Close $271.12 Range $222.39 - $299.21

Q1 2020

Shares 1,163 Value ($000) $277 Avg Close $229.39 Range $197.47 - $249.85

Q4 2019

Shares 1,263 Value ($000) $277 Avg Close $202.38 Range $165.23 - $225.66

Q4 2012

Shares 7,434 Value ($000) $311 Avg Close — Range —

Q3 2012

Shares 5,573 Value ($000) $311 Avg Close — Range —

Q2 2012

Shares 5,570 Value ($000) $311 Avg Close — Range —

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	5,038	$2,395	$431.03	$392.50 - $464.44
Q3 2025	5,077	$2,119	$417.92	$362.50 - $484.56
Q2 2025	5,087	$2,320	$460.83	$416.60 - $510.77
Q1 2025	4,742	$2,299	$466.00	$397.25 - $519.68
Q4 2024	6,178	$2,488	$463.53	$377.85 - $519.88
Q3 2024	5,000	$2,325	$480.37	$456.07 - $510.64
Q2 2024	4,992	$2,340	$434.05	$391.01 - $486.43
Q1 2024	4,860	$1,994	$422.74	$403.43 - $448.40
Q4 2023	4,862	$1,978	$369.42	$341.85 - $413.00
Q3 2023	4,851	$1,687	$349.73	$335.82 - $367.00
Q2 2023	4,861	$1,711	$336.94	$313.47 - $354.94
Q1 2023	4,873	$1,535	$299.93	$282.21 - $325.19
Q4 2022	4,948	$1,429	$304.77	$283.58 - $324.75
Q3 2022	4,918	$1,424	$287.72	$271.61 - $305.95
Q2 2022	4,812	$1,389	$267.66	$233.01 - $293.17
Q1 2022	5,773	$1,507	$237.33	$214.66 - $263.58
Q4 2021	5,774	$1,268	$194.45	$176.36 - $224.49
Q3 2021	2,435	$442	$195.24	$180.02 - $204.88
Q2 2020	1,169	$339	$271.12	$222.39 - $299.21
Q1 2020	1,163	$277	$229.39	$197.47 - $249.85
Q4 2019	1,263	$277	$202.38	$165.23 - $225.66
Q4 2012	7,434	$311	—	—
Q3 2012	5,573	$311	—	—
Q2 2012	5,570	$311	—	—